BROADWOOD CAPITAL INC Long-Term Concentrated

CIK: 0001278387 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value ($000): $1,173,335 (100.0% shares, 0.0% debt)

Holdings (7)

MNST MONSTER BEVERAGE CORP NEW 41.7%

Value ($000) $488,995 Shares 8,488,017 Est. Cost $36.99 Unrealized +44.5%

STAA STAAR SURGICAL CO 28.0%

Value ($000) $328,886 Shares 10,537,835 Est. Cost $14.31 Unrealized +151.0%

AXON AXON ENTERPRISE INC 16.7%

Value ($000) $196,347 Shares 760,062 Est. Cost $27.50 Unrealized +719.6%

IWM ISHARES TR 9.7%

Value ($000) $113,602 Shares 566,000 Est. Cost $112.69 Unrealized —

LCTX LINEAGE CELL THERAPEUTICS IN 3.2%

Value ($000) $38,080 Shares 34,935,485 Est. Cost $1.04 Unrealized +4.9%

IMDX ONCOCYTE CORP 0.5%

Value ($000) $6,273 Shares 2,509,066 Est. Cost $3.72 Unrealized -17.3%

— AGEX THERAPEUTICS INC 0.1%

Value ($000) $1,154 Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MNST	MONSTER BEVERAGE CORP NEW	8,488,017	$488,995	41.7%	$36.99	+44.5%	COM	61174X109
STAA	STAAR SURGICAL CO	10,537,835	$328,886	28.0%	$14.31	+151.0%	COM PAR $0.01	852312305
AXON	AXON ENTERPRISE INC	760,062	$196,347	16.7%	$27.50	+719.6%	COM	05464C101
IWM	ISHARES TR	566,000	$113,602	9.7%	$112.69	—	RUSSELL 2000 ETF	464287655
LCTX	LINEAGE CELL THERAPEUTICS IN	34,935,485	$38,080	3.2%	$1.04	+4.9%	COM	53566P109
IMDX	ONCOCYTE CORP	2,509,066	$6,273	0.5%	$3.72	-17.3%	COM NEW	68235C206
—	AGEX THERAPEUTICS INC	2,997,156	$1,154	0.1%	$2.99	—	COM	00848H108